Envision Pharma Group
Emily Chu has a work experience spanning over 10 years. Emily started their career as a Medical Writer at ESP Bioscience in 2011 and worked there until 2013. Later, they worked as a Freelance Scientific Proofreader at Proof-Reading-Service.com Ltd from 2013 to 2014. In 2014, they joined Thrombosis Research Institute as a Medical Writer and stayed until 2017. Currently, they are working at Envision Pharma Group, where they started as a Senior Medical Writer in 2018 and now holds the position of Scientific Director since January 2022.
Emily Chu obtained a Bachelor of Science degree in Biology from Imperial College London between 2000 and 2003. Following this, they pursued a PhD in Endocrinology at Queen Mary University of London from 2003 to 2007.
This person is not in any offices
Envision Pharma Group
1 followers
The Envision Pharma Group is an innovative scientific communications and technology company, focused on the life science industry working with clients, authors, and the medical publishing community to develop and execute evidence-based communication programs in a transparent and compliant manner.